Zomedica CEO Provides Update to Shareholders
ANN ARBOR, MI / ACCESSWIRE / January 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Day: January 10, 2022
Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
Collaboration will combine Carisma's engineered macrophage technology with Moderna's mRNA and LNP technologies to generate and develop in vivo CAR-M...
NeuroMetrix Names Strategic Growth Executive, Brandi Damkier, as Vice President, Clinical Partnerships
WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has appointed Brandi Damkier...
NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programs
After a transformative year in 2021, NGM Bio enters 2022 with a diverse pipeline of seven disclosed programs, including four...
Assertio Holdings, Inc. to Participate in the H.C. Wainwright BioConnect Virtual Conference
LAKE FOREST, Ill., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced...
Artelo Biosciences Leadership to Participate on Endocannabinoid Panel at the H.C. Wainwright BioConnect 2022 Virtual Conference
Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright ConferenceSOLANA BEACH, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE)...
Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies
Delivery of 100,000 samples of capacity annually to the market, empowering genomics researchers to add deep, unbiased proteomics analysis to...
HealthEquity Announces Record HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference
DRAPER, Utah., Jan. 10, 2022 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent...
Castellum, Inc. Announces Promotion of Glen Ives to President of Government Sales and Operations; Additional Executive Moves Noted
Castellum, Inc. Announces Promotion of Glen Ives to President of Government Sales and Operations; Additional Executive Moves Noted Castellum, Inc....
CareCentrix Named a 2022 “Fierce 15” Company by Fierce Healthcare
Fierce Recognizes CareCentrix’s HomeFirstSM Analytics and Hyper-Personalized Care Model as Innovations in Health at Home HARTFORD, Conn., Jan. 10, 2022...
Junshi Biosciences and Coherus Expand Immuno-Oncology Collaboration to Include TIGIT-Targeted Antibody
Junshi Biosciences and Coherus plan to evaluate the toripalimab + JS006 combination in clinical trials in multiple tumor typesCombinations of...
Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January
WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the...
Clover Health Beats Expectations with Medicare Advantage Membership Growing by Over 25% at the Start of 2022
Fueled by strong performance in New Jersey and GeorgiaNASHVILLE, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq:...
NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021
Technology is awarded for its advances in mental healthMALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),...
BrightInsight Announces Partnership with Sanofi to Bring to Market a Next Generation Digital Companion Application
BrightInsight’s Platform has been selected to Accelerate Continuous Development of one of Sanofi’s Best-In-Class Software as a Medical DeviceSAN JOSE,...
Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021
ROSELAND, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2022
BURNABY, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today outlined its...
Sienna Senior Living Inc. Provides Business Update and Announces Addition to its Board of Directors
MARKHAM, Ontario, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today provided...
Scopus BioPharma Provides Update Following Annual Meeting of Stockholders
Overwhelming Majority of Shares Voted by Unaffiliated Stockholderswere in Favor of Scopus' Director Nominees Lasters’ Ownership Position and Annual Meeting...
Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO Transition
SEATTLE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) today reported preliminary, unaudited revenue for the year...